TRIB
Trinity Biotech
TRIB
TRIB
79 hedge funds and large institutions have $203M invested in Trinity Biotech in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 36 increasing their positions, 22 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
99% less call options, than puts
Call options by funds: $1K | Put options by funds: $117K
Holders
79
Holding in Top 10
3
Calls
$1K
Puts
$117K
Top Buyers
| 1 | +$4.06M | |
| 2 | +$3.92M | |
| 3 | +$2.79M | |
| 4 |
LAM
Lapides Asset Management
Greenwich,
Connecticut
|
+$1.76M |
| 5 |
RA
Royce & Associates
New York
|
+$1.13M |
Top Sellers
| 1 | -$8.86M | |
| 2 | -$4.04M | |
| 3 | -$2.89M | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.21M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.1M |